Heart Health Inc. To Conduct a Feasibility Study on Product Placement for Heart Health Monitor

Heart Health, Inc. (PINK SHEETS: HHEL) is pleased to announce that the Company is exploring an opportunity to engage a marketing and research company to conduct a feasibility study concerning the product placement of the Heart Health Monitor. Currently, cardiovascular products earn approximately $29.4 billion in annual sales.

Heart Health Inc. intends to engage the services of a marketing and research company to assist with conducting surveys to determine the size and scope of the market for the one-lead, USB-enabled Heart Health Monitor. Heart Health’s goal is to ascertain the number of units the Company would initially produce for its rollout and how to reach specific target markets to reap the most benefits for its product. Research companies provide customized, timely and relevant market research solutions in a variety of areas from product positioning and total unduplicated reach and frequency analysis, to focus groups and opinion surveys.

“We have a great product that we believe will be an enormous benefit to the medical community. Through this endeavor we want to determine the best approach to market our Heart Health Monitor to reach the most people, generate revenue and maximize our shareholders’ value,” stated Michael Kron, Chairman and CEO of Heart Health, Inc.

Heart Health Inc. is in the process of finalizing the patent application it will file with the U.S. Patent and Trademark Office for the USB enabled Heart Health Monitor (HHM). The non-invasive HHM provides on-demand EKG results for patients who either require monitoring, or have a history of heart disease in the family. The device enables a trained medical professional to make a more in depth diagnosis of the user’s heart condition.

About Heart Health, Inc.:

Heart Health, Inc. is focused on the development and marketing of innovative, cardiovascular medical device products. The Company intends to revolutionize the way in which people monitor the health of their hearts using newly acquired products such as the Heart Health Monitor.

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

 Contacts: Heart Health, Inc. Investor Relations 1-866-THE APPL(E)  

SOURCE: Heart Health, Inc.